These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Renal structure and function effects after low dose cyclosporine in psoriasis patients: a preliminary report. Messana JM; Johnson KJ; Mihatsch MJ Clin Nephrol; 1995 Mar; 43(3):150-3. PubMed ID: 7774069 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II as a risk factor for cyclosporin nephrotoxicity in patients with psoriasis. Edwards BD; Chalmers RJ; O'Driscoll JB; Mitchell DM; Smith RJ; Lawson RS; Testa HJ; Ballardie FW Clin Nephrol; 1994 Jun; 41(6):350-6. PubMed ID: 8076438 [TBL] [Abstract][Full Text] [Related]
6. Fish oil and cyclosporin A-induced renal hypoperfusion in kidney-transplanted patients. Hansen JM; Høy CE; Strandgaard S Nephrol Dial Transplant; 1995; 10(9):1745-50. PubMed ID: 8559499 [TBL] [Abstract][Full Text] [Related]
7. Interrelationship between serum concentrations of 1,25-dihydroxyvitamin D, parathyroid hormone and renal haemodynamics after low dose cyclosporin. Edwards BD; Davies M; Mawer EB; Chalmers RJ; Testa HJ; Ballardie FW Miner Electrolyte Metab; 1994; 20(5):250-4. PubMed ID: 7700211 [TBL] [Abstract][Full Text] [Related]
8. Effects of cyclosporin A withdrawal on renal function and renal stimulation in liver transplant patients treated with triple-drug immunosuppression for over 2 years. Klompmaker IJ; Homan van der Heide JJ; Tegzess AM; Meijer S; Haagsma EB; Verwer R; Slooff MJ Nephrol Dial Transplant; 1994; 9(11):1629-33. PubMed ID: 7870353 [TBL] [Abstract][Full Text] [Related]
9. Can maintenance cyclosporine be used in psoriasis without decreasing renal function? Silverman AK; Emmett M; Menter A Semin Dermatol; 1992 Dec; 11(4):302-12. PubMed ID: 1493094 [TBL] [Abstract][Full Text] [Related]
10. Modifying effects of amlodipine on cyclosporin A-induced changes in renal function in patients with psoriasis. Raman GV; Campbell SK; Farrer A; Albano JD; Cook J J Hypertens Suppl; 1998 Sep; 16(4):S39-41. PubMed ID: 9817191 [TBL] [Abstract][Full Text] [Related]
11. Modulation of abnormalities in renal haemodynamics and vasoactive mediators by nifedipine in patients with psoriasis on low-dose cyclosporin. Edwards BD; Chalmers RJ; O'Driscoll J; Lawson RS; Testa HJ; Ballardie FW Nephrol Dial Transplant; 1993; 8(10):1071-8. PubMed ID: 8272218 [TBL] [Abstract][Full Text] [Related]
12. Renal outcome after ciclosporin-induced nephrotoxicity. Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700 [TBL] [Abstract][Full Text] [Related]
13. Detailed study of changes in renal function after conversion from cyclosporine to azathioprine. Hilbrands LB; Hoitsma AG; Wetzels JF; Koene RA Clin Nephrol; 1996 Apr; 45(4):230-5. PubMed ID: 8861797 [TBL] [Abstract][Full Text] [Related]
14. Acute renal and immunological effects of low-dose cyclosporin in humans. De Nicola L; Libetta C; Memoli B; Bellizzi V; Colucci G; Imperatore P; Taccone W; Oriente L; Sepe V; Conte G Nephrol Dial Transplant; 1995; 10(9):1739-44. PubMed ID: 8559498 [TBL] [Abstract][Full Text] [Related]
15. Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis. Sund S; Førre O; Berg KJ; Kvien TK; Hovig T Clin Nephrol; 1994 Jan; 41(1):33-40. PubMed ID: 8137567 [TBL] [Abstract][Full Text] [Related]
16. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing. Bunke M; Sloan R; Brier M; Ganzel B Transplantation; 1995 Feb; 59(4):537-40. PubMed ID: 7878758 [TBL] [Abstract][Full Text] [Related]
17. Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients: potential pathophysiologic role of endothelin. Pei Y; Chan C; Cattran D; Cardella C; Zaltzman J; Lopez M; Tong J; Schachter R; Maurer J J Lab Clin Med; 1995 Jan; 125(1):113-9. PubMed ID: 7822939 [TBL] [Abstract][Full Text] [Related]
18. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients? Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945 [TBL] [Abstract][Full Text] [Related]
19. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis. Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948 [TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]